Compare ANL & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ANL | PVL |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 325.5M | 57.8M |
| IPO Year | 2022 | N/A |
| Metric | ANL | PVL |
|---|---|---|
| Price | $7.95 | $1.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 215.2K | 135.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.78% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $1.30 |
| 52 Week High | $12.09 | $2.04 |
| Indicator | ANL | PVL |
|---|---|---|
| Relative Strength Index (RSI) | 47.12 | 56.88 |
| Support Level | $7.21 | $1.72 |
| Resistance Level | $9.98 | $1.88 |
| Average True Range (ATR) | 1.05 | 0.08 |
| MACD | -0.31 | 0.02 |
| Stochastic Oscillator | 25.68 | 65.63 |
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.